Osteoporosis Disease Management Demonstration Project (0000-040)

Merck Sharp & Dohme LLC230 enrolled

Overview

The purpose of the study is to evaluate the impact disease management interventions in treatment compliance among post-fracture and osteoporosis patients.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Masking

NONE

Enrollment

230

Conditions

Osteoporosis

Interventions

Disease Management AssessmentBEHAVIORAL

Eligibility

Sex: FEMALEMin age: 60 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Members of of the Kaiser Permanente Health Plan who have fractured a bone. Exclusion Criteria: * Individuals who are not members of the Kaiser Permanente Health Plan.

Outcomes

Primary Outcomes

Treatment persistence

Secondary Outcomes

Patient satisfaction and knowledge

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.